Results 21 to 30 of about 187,331 (234)

The Association and Predictive Value of Lipid Ratios to Metabolic Syndrome: a Multistage Cross-sectional Study [PDF]

Zhongguo quanke yixue, 2023
Background With the growing incidence of metabolic diseases, there has been increasing attention given to the prevention and control of metabolic syndrome (MS) .
ZHOU Shiyu, CHEN Shaolin, DENG Renli, DAI Mi, LIU Tao, TIAN Kunming
doaj   +1 more source

Pharmacists' Utilization of Non-HDL-C Levels in Managing Patients With Lipid Disorders. [PDF]

Hosp Pharm, 2021
Background: Since 2013 there have been cholesterol guideline changes impacting pharmacists’ clinical practice in managing lipid disorders. For more than a decade, cholesterol management was based on the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol Adult Treatment Panel III ...
Plakogiannis R, Saseen JJ, Stefanidis A.
europepmc   +3 more sources

Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients

BMC Nephrology, 2020
Background and aims Dyslipidemia is common in patients with chronic kidney disease and particular prevalent in patients receiving peritoneal dialysis. However, whether markers of atherogenic dyslipidemia correlate with outcomes in dialysis patients as in
Wenkai Xia, Xiajuan Yao, Yan Chen, Jie Lin, Volker Vielhauer, Hong Hu   +5 more
doaj   +1 more source

High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study

BMC Cardiovascular Disorders, 2021
Background Dyslipidaemia refers to lipid abnormalities consisting of either one or any combination of the following: elevated total cholesterol (TC), elevated low-density lipoprotein cholesterol (LDL-c), elevated triglycerides (TG), and low high-density ...
Mohamed-Syarif Mohamed-Yassin, Noorhida Baharudin, Aqil Mohammad Daher, Najmin Abu Bakar, Anis Safura Ramli, Suraya Abdul-Razak, Nor-Ashikin Mohamed Noor Khan, Mariam Mohamad, Khalid Yusoff   +8 more
doaj   +1 more source

Association Between Lipid-Lowering Therapy and Differences in the Distribution of LDL-C, apoB and non-HDL-C. [PDF]

J Clin Med
Background: The diagnosis of hypercholesterolemia relies on the laboratory assessment of lipid parameters. This study aimed to evaluate differences in the distribution of low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and apolipoprotein B (apoB) concentrations according to the presence and type of ...
Ziółkowski M, Obońska K, Ratajczak J, Adamski P, Banach M, Chlebus K, Grzelakowska K, Jankowski P, Krintus M, Kryś J, Laskowska E, Mrzywka N, Niezgoda P, Ostrowska M, Podhajski P, Skonieczny G, Sosnowska B, Szarpak Ł, Topolska M, Umińska J, Rzepka-Cholasińska A, Navarese EP, Kubica J.   +22 more
europepmc   +3 more sources

NHHR: An Important Independent Risk Factor for Patients with STEMI

Reviews in Cardiovascular Medicine, 2022
Background: In this study, we investigated whether the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) is associated with the development of acute ST-segment elevation myocardial infarction (STEMI ...
Po Gao, Jing Zhang, Xizhen Fan
doaj   +1 more source

Utility of non-HDL-C and apoB targets in the context of new more aggressive lipid guidelines. [PDF]

Am J Prev Cardiol, 2021
Major guidelines recommend the use of secondary targets, such as non-HDL-C and apoB, to further reduce cardiovascular risk. We aimed to evaluate the proportion at which newer, more aggressive secondary lipid targets are exceeded in patients with LDL-C 
Quispe R, Brownstein AJ, Sathiyakumar V, Park J, Chang B, Sajja A, Guallar E, Lazo M, Jones SR, Martin SS.   +9 more
europepmc   +4 more sources

Non-HDL-C vs. LDL-C in Predicting the Severity of Coronary Atherosclerosis [PDF]

Heart, Lung and Circulation, 2016
Atherosclerosis is a complex process involving multiple interfaces among inflammation, hypertension, age, ectopic obesity, diabetes, metabolic syndrome, dyslipidaemias, poor diet, smoking, sedentary lifestyle, impaired immune system, endothelial, vascular, hormonal and coagulation [1–3]. Dyslipidaemia is a risk factor for coronary artery disease (CAD),
Roever, Leonardo, Biondi-Zoccai, Giuseppe, Chagas, Antonio Carlos Palandri   +2 more
openaire   +4 more sources

Walking and Non‐HDL‐C in Adults: A Meta‐Analysis of Randomized Controlled Trials [PDF]

Preventive Cardiology, 2005
An elevated level of non‐high‐density lipoprotein cholesterol (non‐HDL‐C) is a major risk factor for cardiovascular disease. The purpose of this study was to use the meta‐analytic approach to examine the effects of walking on non‐HDL‐C in adults.
George A, Kelley, Kristi S, Kelley, Zung Vu, Tran   +2 more
openaire   +2 more sources

Metabolic and Inflammatory Relationship between Covid-19 and Non-HDL-C. [PDF]

Arq Bras Cardiol, 2023
Alves RJ.
europepmc   +3 more sources